Wegovy (Semaglutide Injection) Wegovy stands out as an FDA-approved weight loss solution, using the same semaglutide found in Ozempic but specifically designed for those with a BMI of 30 or higher, or 27 or higher with additional weight-related conditions
However, our standard protocol for many patients is: Medications prescribed through Direct Meds are dispensed by U.S.-based 503A compounding pharmacies
We throw them back
21, 2025, the FDA determined that the semaglutide shortage is over, giving compounding pharmacies a deadline for ceasing the distribution of compounded versions of injectable semaglutide that are essentially identical to FDA-approved versions (e.g., Wegovy and Rybelsus)
Reduces Inflammation & Oxidative Stress Acts as a powerful anti-inflammatory and antioxidant peptide
Digging into the details: 45 of the 49 telehealth platforms issued a prescription for the simulated patient, mostly for compounded GLP-1 medications